How to Indicate Implantable Cardioverter‐Defibrillator in Patients With Malignancy

How to Indicate Implantable Cardioverter‐Defibrillator in Patients With Malignancy

Saved in:

Bibliographic Details
Main Authors:	Naoya Kataoka, Teruhiko Imamura
Format:	Article
Language:	English
Published:	Wiley 2025-08-01
Series:	Journal of Arrhythmia
Subjects:	amiodarone cardiomyopathy ventricular tachyarrhythmia
Online Access:	https://doi.org/10.1002/joa3.70148
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

How to demonstrate the clinical implication of prophylactic implantable cardioverter–defibrillator in patients with advanced light chain amyloidosis
by: Naoya Kataoka, et al.
Published: (2025-06-01)

How to indicate implantable cardioverter‐defibrillator in the aging population
by: Risako Orita, et al.
Published: (2025-04-01)

Prognostic comparison between implantable cardioverter‐defibrillator and amiodarone in cancer patients
by: Hirota Kida, et al.
Published: (2025-06-01)

DX single-lead implantable cardioverter-defibrillator system with a floating atrial dipole: when, to whom, and why?
by: A. V. Prokopenko, et al.
Published: (2023-06-01)

Navigating the Uncommon: Case Report of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Successfully Managed with Implantable Cardioverter Defibrillator (ICD)
by: Sidhi Laksono Purwowiyoto, et al.
Published: (2024-10-01)

EFFICACY OF CARDIOVERTER-DEFIBRILLATORS IN PREVENTION OF SUDDEN DEATH AND OVERALL MORTALITY DECREASE IN PATIENTS WITH THE SYNDROME OF DILATION CARDIOMYOPATHY: DIFFERENTIAL APPROACH
by: O. V. Blagova, et al.
Published: (2018-03-01)

AMIODARONE THYROTOXICOSIS IN A PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
by: P. Kh. Dzhanashiya, et al.
Published: (2009-06-01)

URGENT CATHETER ABLATION OF THE ELECTRICAL STORM IN PATIENTS WITH IMPLANTED CARDIOVERTER-DEFIBRILLATOR
by: R. B. Tatarsky, et al.
Published: (2015-11-01)

Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)

A Case Report on USG-Guided Stellate Ganglion Block in Refractory Ventricular Tachycardia
by: Anwesha Banerjee, et al.
Published: (2025-06-01)

Appropriate implantable cardioverter-defibrillator therapy triggered by heat stroke
by: Carlos Fernando Paz Mamani, et al.
Published: (2025-01-01)

A new marker for ventricular tachyarrhythmias in patients with postinfarction left ventricular aneurysm: Big endothelin-1
by: Tufan Çınar, et al.
Published: (2020-02-01)

Comparative analysis of implantable cardioverter-defibrillator efficacy in ischemic and non-ischemic cardiomyopathy in patients with heart failure
by: Emre Demir, et al.
Published: (2025-07-01)

Clinical, morphological and genetic characteristics of young patients with hypertrophic cardiomyopathy with indications for implantable cardioverter-defibrillator
by: V. G. Davydova, et al.
Published: (2024-12-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

Analysis of electrotherapy of cardioverter defibrillators implanted for the primary prevention of sudden cardiac death
by: V. K. Lebedeva, et al.
Published: (2019-08-01)

Possibilities for predicting ventricular tachyarrhythmias in patients with heart failure with reduced ejection fraction based on surface electrocardiography. First results from a single-center prospective study
by: N. N. Ilov, et al.
Published: (2022-01-01)

Mitochondrial DNA Polymorphisms of Peripheral Blood Mononuclear Cells Associated with Sustained Ventricular Tachycardia in Patients with Cardioverter-Defibrillator Implantation Indications
by: Tariel Atabekov, et al.
Published: (2025-03-01)

COMPARATIVE EFFICACY OF AMIODARONE AND BISOPROLOL IN TREATMENT OF VENTRICULAR PREMATURE BEATS IN PATIENTS WITH METABOLIC SYNDROME
by: V. M. Provotorov, et al.
Published: (2016-01-01)

Cardiac Complications Post Parathyroidectomy: A Systematic Review
by: Arun K. R. Pande, et al.
Published: (2025-03-01)

Non-compaction cardiomyopathy. Part I: clinical and genetic heterogeneity and predictors of unfavorable prognosis
by: T. G. Vaikhanskaya, et al.
Published: (2020-12-01)

Importance of blood biomarker determination in the selection of patients with heart failure for cardioverterdefibrillator implantation
by: N. N. Ilov, et al.
Published: (2023-11-01)

Perspectives on the Use of Transthoracic Echocardiography Results for the Prediction of Ventricular Tachyarrhythmias in Patients with Non-ischemic Cardiomyopathy
by: N. N. Ilov, et al.
Published: (2022-07-01)

Changes of NT-proBNP and sST2 levels for predicting isolated episodes of ventricular tachyarrhythmias and electrical storm in patients with systolic heart failure and various implanted devices
by: A. Zh. Gasparyan, et al.
Published: (2020-12-01)

Clinical and anamnestic predictors of poor long-term prognosis in patients with chronic heart failure and implanted cardioverter-defibrillator
by: Nataliya B. Lebedeva, et al.
Published: (2025-01-01)

THE POSSIBILITIES OF ANTIARRHYTHMIC THERAPY IN PRIMARY PREVENTION OF DEATH IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS
by: Yu. A. Bunin
Published: (2016-01-01)

Comparative Efficacy of Amiodarone and Lidocaine in Treating Cardiac Arrest Due to Ventricular Fibrillation and Pulseless Ventricular Tachycardia in Adults. A Literature Review
by: Patryk Dryja, et al.
Published: (2024-12-01)

Contemporary medical therapy, sex-specific characteristics, and outcomes of patients with non-ischemic cardiomyopathy: a prespecified interim analysis of the BIO-LIBRA studyResearch in context
by: Valentina Kutyifa, et al.
Published: (2025-08-01)

Thyroidectomy in patients with amiodarone-induced thyrotoxicosis
by: U. A. Tsoy, et al.
Published: (2021-08-01)

SAFETY OF AMIODARONE USAGE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL FIBRILLATION
by: D. A. Kuzhel, et al.
Published: (2016-01-01)

Long‐term safety and efficacy of subcutaneous implantable cardioverter‐defibrillator compared with transvenous implantable cardioverter‐defibrillator in propensity score‐matched patients from Japan
by: Yuki Konno, et al.
Published: (2025-04-01)

Battery Longevity in Modern Implantable Cardioverter‐Defibrillators and Cardiac Resynchronization Therapy‐Defibrillators
by: Kotaro Nishino, et al.
Published: (2025-08-01)

Heart rate turbulence and T wave alternation in myocardial electrical instability diagnostics
by: A. E. Radzevich, et al.
Published: (2006-10-01)

Cardiac resynchronization therapy: potential for arrhythmic risk modification
by: N. N. Ilov, et al.
Published: (2023-06-01)

Safety and Tolerability of Implanted Subcutaneous Cardioverter-Defibrillator Systems
by: A. V. Vereshchagina, et al.
Published: (2022-09-01)

MEDICINAL LUNG INJURY: CLINICAL OBSERVATION
by: N. A. Karoli, et al.
Published: (2014-07-01)

Amiodarone treatment in cats: evaluation of indications, adverse effects, and survival outcomes
by: Graham C. Rossi, et al.
Published: (2025-01-01)

Customizing solutions: Ventricular tachycardia and implantable cardioverter-defibrillator programming
by: Tatiana Pavlenko, et al.
Published: (2024-12-01)

Depression and Implantable Cardioverter‐Defibrillator Implantation in Black Patients at Risk for Sudden Cardiac Death
by: Brian C. Boursiquot, et al.
Published: (2024-07-01)

Complications of Implantable Cardioverter Defibrillator and Their Potential Risk Factors in Patients with Hypertrophic Cardiomyopathy
by: Mohammad Taghi Hedayati Goudarzi, et al.
Published: (2023-01-01)